Thermo Fisher Scientific, Inc.

Thermo Fisher Scientific, Inc. has recently revised its evaluation amid changing market conditions. The company's stock is currently priced at $516.00, reflecting significant volatility over the past year. While its short-term indicators show mixed trends, the company has outperformed the S&P 500 over the past decade.

Thermo Fisher Scientific, Inc. has recently experienced a technical trend adjustment, with its stock price reflecting a slight decline. The company has shown significant price fluctuations over the past year. Performance indicators present a mixed outlook, and stakeholders are advised to monitor the evolving market dynamics closely.

Thermo Fisher Scientific, Inc. has experienced a notable stock price adjustment, currently at $473.36, down from $488.85. The stock has shown significant volatility over the past year. Technical indicators present mixed signals, while the company's performance has lagged behind the S&P 500 in recent months but outperformed over the last decade.

Thermo Fisher Scientific, Inc. experienced a decline in stock value on March 27, 2026, amid broader market trends. Over the past week and month, the company has faced negative performance, yet it maintains a strong ability to service its debt and demonstrates solid long-term growth potential.

Thermo Fisher Scientific, Inc. has recently revised its stock evaluation amid market fluctuations, currently priced at $470.21. The stock has shown significant volatility over the past year, with a high of $643.99 and a low of $385.46, while underperforming compared to the S&P 500.

Thermo Fisher Scientific, Inc. faced a challenging trading session, with its stock price declining significantly. The company has experienced notable decreases over various time frames, including year-to-date performance. Despite these challenges, it shows strong debt servicing capability and long-term growth potential, with increasing net sales.

Thermo Fisher Scientific, Inc. saw a significant stock decline today, contrasting with the broader market. Despite recent fluctuations, the company shows strong financial health, with solid EBIT to interest ratios and consistent long-term growth in net sales and operating profit. Its market capitalization is USD 214.8 billion.

Thermo Fisher Scientific, Inc. has recently adjusted its valuation, with a current P/E ratio of 26 and a Price to Book Value of 3.44. The company has shown mixed performance, with a 2.69% stock return over the past week, while its year-to-date return lags behind the S&P 500.

Thermo Fisher Scientific, Inc. has recently revised its evaluation amid notable shifts in technical indicators. The stock price is currently $543.95, with a significant 52-week range. Performance metrics show mixed signals, and while the company has outperformed the S&P 500 recently, it has underperformed over the past year.

Thermo Fisher Scientific, Inc. saw a significant rise in stock performance on October 3, 2025, reaching an intraday high. The company has demonstrated strong momentum over the past week and month, although it has faced challenges over the past year. Its financial health remains solid, supported by robust growth and high institutional ownership.

Thermo Fisher Scientific, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. The stock has outperformed the S&P 500, showing a significant weekly increase. Key technical indicators present a mixed outlook, suggesting a complex market environment as investor sentiment evolves.